Target intelligence / Profile preview

Disulfide bonds in mucus glycoproteins

Molecular classification
Structural protein component, Post-translational modification
01

Overview

Disulfide bonds in mucus glycoproteins, specifically mucins, are the primary covalent cross-links responsible for the polymerization of mucin monomers into expansive gel-forming networks (StatPearls, 2023). These bonds are formed between cysteine residues in the amino- and carboxy-terminal domains of mucin proteins, such as MUC5AC and MUC5B, and their density directly determines the viscoelasticity and rheological properties of the mucus layer (Thorax, 2013). In chronic respiratory diseases like cystic fibrosis and COPD, excessive disulfide cross-linking leads to hyper-viscous mucus that obstructs the airways and impairs mucociliary clearance (Journal of Clinical Medicine, 2019). Pharmacological intervention typically involves thiol-based mucolytic agents like N-acetylcysteine, which possess free sulfhydryl groups that interact with the target through a thiol-disulfide exchange reaction (PubChem, 2024). This chemical reduction results in the depolymerization of the mucin network, significantly lowering mucus viscosity and facilitating expectoration. Beyond the lungs, targeting these bonds is also relevant in treating ocular conditions where abnormal mucus consistency causes irritation.

Other names
Mucin disulfide bridgesCystine linkages in mucinsIntermolecular disulfide bonds in mucinsThiol-disulfide exchange target
02

Mechanism of action

Reduction of disulfide bonds via thiol-disulfide exchange, leading to the depolymerization of mucin networks and reduction of mucus viscosity.

03

Biological functions

Protein polymerizationMucus gel formationViscoelasticity regulationStructural integrity of mucosal barriers
04

Disease associations

Chronic obstructive pulmonary disease (COPD)Cystic fibrosisBronchitisAsthmaKeratoconjunctivitis sicca (dry eye syndrome)
05

Safety considerations

Bronchospasm (especially with inhaled administration)Gastrointestinal irritationDisruption of protective mucosal barriersUnpleasant sulfur-like odor
06

Interacting drugs

N-acetylcysteine

4 more in the full profile.

07

Biomarkers

Sputum viscosityMucociliary clearance rateForced expiratory volume in 1 second (FEV1)

Beyond the preview

Go deeper on Disulfide bonds in mucus glycoproteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Disulfide bonds in mucus glycoproteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call